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Abstract
Background: Tandem mass spectrometry (MS/MS) has become the primary way for protein
identification in proteomics. A good score function for measuring the match quality between a
peptide and an MS/MS spectrum is instrumental for the protein identification. Traditionally the to-
be-measured peptides are fragmented with the collision induced dissociation (CID) method. More
recently, the electron transfer dissociation (ETD) method was introduced and has proven to
produce better fragment ion ladders for larger and more basic peptides. However, the existing
software programs that analyze ETD MS/MS data are not as advanced as they are for CID.
Results: To take full advantage of ETD data, in this paper we develop a new score function to
evaluate the match between a peptide and an ETD MS/MS spectrum. Experiments on real data
demonstrated that this newly developed score function significantly improved the de novo
sequencing accuracy of the PEAKS software on ETD data.
Conclusion: A new and better score function for ETD MS/MS peptide identification was
developed. The method used to develop our ETD score function can be easily reused to train new
score functions for other types of MS/MS data.
Background
In recent years, tandem mass spectrometry (MS/MS) has
become a popular technique in proteomics for protein
identification. In a typical “bottom-up” approach, pro-
teins are enzymatically digested into short peptides, each
of them is measured with MS/MS and produces an MS/MS
spectrum. Analytical software is used to identify a peptide
for each qualified spectrum. Then the peptides are used
for protein identification and characterization. Many
software programs (e.g. Mascot, Sequest and PEAKS)
have been developed for MS/MS data analysis [1-6].
Database search and de novo sequencing are two main
approaches for peptide identification from MS/MS data.
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and tries to find a peptide from the database that best
explains the MS/MS spectrum. De novo sequencing does
not require a sequence database, and instead constructs a
peptide sequence from scratch to best explain the MS/MS
spectrum. Algorithms and software developments using
these two approaches have been one of the research
focuses in bioinformatics community recently. Some
exemplary work for database search approach can be
found in [1,2,7-10], and for de novo sequencing approach
can be found in [3,11-18].
Both approaches identify peptides with two steps. First, a
set of candidate peptides are selected either from a
protein database or with a sequence construction
algorithm for a given spectrum. Second, each sequence
candidate is evaluated with a score function that
measures the quality of the match between the sequence
and the spectrum, and the peptide with the best
matching score is then output. Inevitably, the quality
of the score function greatly affects the quality of the
peptide identification and its following analysis. In a
tandem mass spectrometer, a peptide ion is fragmented
into fragment ions. Normally, the fragmentation can
occur at any position of the peptide backbone, resulting
in different types of fragment ions (Figure 1(a)). Each
ion will result in a peak at the corresponding mass to
charge ratio (m/z), and all the ions together form a
theoretical mass spectrum (Figure 1(b)). The real MS/MS
spectrum is more complicated due to the existence of
noise peaks, the missing of some fragment ion peaks,
and the different intensities of each peak (Figure 2).
The collision induced dissociation (CID) is among the
earliest ways developed for peptide fragmentation in a
tandem mass spectrometer, and is also the most widely
studied in bioinformatics. It is known to produce more y
and b-ions than the other ion types. Recently, more
fragmentation mechanisms such as infrared multipho-
ton dissociation (IRMPD) [19], electron capture dis-
sociation (ECD) [20], and electron transfer dissociation
(ETD) [21] have been developed. Particularly, ETD is
regarded as a promising method complementary to CID
because ETD is better suited for sequencing larger and
more basic peptides.
Due to the importance of the matching score function,
many scoring methods have been proposed. One
straightforward approach is based on the match between
the real spectrum and the theoretical spectrum generated
from a candidate peptide [2,22]. Another approach is
based on the probabilistic model of fragmentation
process [9,12,23,24]. These probabilistic models study
and employ the statistical differences between peaks
produced with different ion types. Frank et al.f u r t h e r
exploited these properties by a probabilistic network for
collision induced dissociation (CID) data to improve the
accuracy of de novo sequencing [13].
Most of the existing score functions are designed and
trained specifically for CID data. ETD spectra differ from
CID spectra in the magnitude and the complexity of
fragment ion signals. Although a few software tools such
as PEAKS and Mascot have been adjusted to work on
ETD data, they are better suited for CID data and give
poorer results with ETD data. To better utilize the
advantage of ETD spectra on longer and more basic
peptides, in this paper, we propose a score function for
ETD data based on a probabilistic model. The experi-
ments on real data showed that the score function
significantly improved the de novo sequencing perfor-
m a n c ew h e nu s e di nt h eP E A K Ss o f t w a r e[ 3 ] .O u r
method for developing this score function is general
enough to be used to develop new score functions for
CID and other types of MS/MS data.
Results
We used an ETD dataset of 9885 spectra from a complex
C. elegans protein mixture digested with trypsin followed
by alkylation with iodoacetamide. The spectra were
acquired on an LTQ Orbitrap XL ETD. The peptide
mixtures were separated with Surveyor LC equipped with
MicroAS autosampler using a reversed phase peptide trap
and a reversed phase analytical column at a flow rate of
Figure 1
Peptide fragmentation. (a) For every two adjacent amino
acid residues, there are three positions where the peptide
backbone can be fragmented, resulting in six types of ions.
(b) Each ion type may generate a peak at the corresponding
m/z value in the theoretical spectrum.
Figure 2
A real tandem mass spectrum.
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90 minutes was employed.
The database search modules in PEAKS 5.0 [3] and
Mascot 2.2 [1] were used for peptide identification. The
tandem mass spectra were matched against NCBI
C. elegans protein sequence database. For both programs,
the error tolerances for parent mass and fragment mass
were set as 10 ppm and 0.8 Da, respectively. Each
program reported no peptide or one best peptide with a
confidence score for each spectrum. (The programs may
report no peptide for low quality spectra.) PEAKS 5.0
reported 1496 peptides and Mascot 2.2 reported 2950
peptides. We applied several filters to remove low
q u a l i t ys p e c t r a .As p e c t r u mi sk e p to n l yi fi ts a t i s f i e s
the following three conditions: (1) the PEAKS con-
fidence score is no less than 50%; (2) the Mascot
confidence score is no less than 30%; and (3) the two
peptides reported by PEAKS and Mascot are the same.
Finally, we selected 259 spectrum-peptide pairs from the
dataset. Both programs identified the peptides consis-
tently with high confidence scores. Thus, the peptides are
very accurate and can be used as positive controls in our
experiments. Among them, 130 spectrum-peptide pairs
are used for training and the remaining 129 pairs are
used for testing.
An ETD spectrum often contains several peaks generated
from its precursor ions. These peaks often have high
intensities, and may affect the performance of the
matching score function. Thus, we removed these
precursor ion peaks from the spectra in data preparation.
Most de novo sequencing software developed so far is for
CID data and does not work for ETD data. The only
software available to us for performance comparison
using ETD data is the PEAKS software [3]. Recent
versions of PEAKS have a built-in set of parameters for
ETD, which was adjusted from its CID parameters. We
compared our score function with the function used in
PEAKS 5.1. To make a fair comparison, the result of our
new score function is obtained by simply replacing the
score function of PEAKS 5.1 without making any change
to the algorithm. Thus, the improvements reported in
the following are purely caused by the difference in the
score functions.
We mainly compared the accuracies of the PEAKS de novo
sequencing results with the two score functions, respec-
tively. There are two ways to define the accuracy:
Accuracy I
number of correctly predicted residues
number of
=
   residues in real peptides
and
Accuracy II
number of correctly predicted residues
number o
=
f f predicted residues
.
Accuracy II is the same as the accuracy defined in [13].
We note that Accuracy II is a fair comparison measure
only if two methods output similar number of predicted
amino acids. Otherwise, the accuracy of the method with
shorter output will be unfairly boosted. For this reason,
we also show the average prediction length of the two
methods in Table 1.
In addition, we search the maximum correct consecutive
subsequences in the predicted peptides. For each
predicted peptide P, the length of the maximum correct
consecutive subsequence is denoted by Lmax(P). We
count the number of predicted peptides with Lmax(P) ≥ l,
for l = 3, 4, ..., 10. The error tolerance for the position of
a predicted amino acid subsequence is 0.6 Da, and the
amino acids leucine(L) and isoleucine(I) are considered
as the same since their mass values are the same.
The testing data contain 129 peptides and 1859 amino
acids. Using the function in PEAKS 5.1 and our score
function, we acquired two sets of predicted peptides,
each contains 129 de novo peptides. The accuracy and the
maximum correct consecutive subsequences of the
resulting peptides are reported in Table 1. The results
show that the new score function significantly improves
the accuracy of de novo sequencing from 32.5% to 55.3%
for Accuracy I, and from 34.2% to 55.9% for Accuracy II.
In PEAKS 5.1, about 56% of predicted peptides contain a
corrected subsequence with length at least 3. For the new
score function, more than half of the predicated peptides
c o n t a i nac o r r e c ts u b s e q u e n c ew i t hl e n g t ha tl e a s t6 .
From the experiments, we conclude that the new score
function has better performance in de novo sequencing
with ETD data than the score function in PEAKS 5.1.
Discussion
We note that the independence assumption in our score
function development in Section Methods is not very
realistic because different types of ions generated by the
fragmentation between the same pair of adjacent
residues of the peptide are often correlated to each
other. To more accurately model this, a probabilistic
network (or Bayesian network) can be used similarly to
[13]. We also tried this approach on our data and found
no apparent improvement over the model used in this
paper. One possible reason is that our training data is of
limited size, and not sufficient to train the many
parameters of the probabilistic network accurately.
Another possible reason is the following. The probabil-
istic network is advantageous over our simple model
only in dealing with the dependence between different
BMC Bioinformatics 2010, 11(Suppl 1):S4 http://www.biomedcentral.com/1471-2105/11/S1/S4
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same pair of adjacent residues). However, when a de novo
sequencing method makes an error at a location,
normally there is either no fragment ion or only one
low fragment ion at the location. Under this condition,
the dependence between different types of fragment ions
is weak. As a result, a model with the independence
assumption would work as well as a more sophisticated
one without this assumption.
Conclusion
In this paper, we proposed a significance level measure-
ment to distinguish signal peaks from noise. Based on
this, a score function for de novo sequencing with ETD
data was defined. Experiments on real data showed that
our score function greatly improved the score function
used in the latest PEAKS 5.1 software. The method used
to develop our ETD score function can be easily reused
to train new score functions for other types of MS/MS
data.
Methods
We first introduce a novel significance level measurement
to evaluate the likelihood that a peak is signal. The
significance level has a better ability to distinguish signal
and noise peaks than the original relative intensities
given by the spectrum. Then, we study the distributions
of the significance levels of different types of fragment
ions, and define a likelihood ratio score for each
fragment ion. Finally, we combine all the fragment ion
scores of a peptide together to provide a peptide score
function.
T h ep e a ks i g n i f i c a n c el e v e l
The peptide fragmentation mechanism shown in
Figure 1(a) and 1(b) is overly simplified. In a real
mass spectrum (Figure 2), there are also many noise
peaks that cannot be explained by the six types of
fragment ions. Meanwhile, not all of these fragment ions
form strong peaks in the spectrum. Some are either
absent or too low to be distinguished from the noise.
Different spectra, and even different regions of the same
spectrum, may have different noise and signal levels.
Consequently, the intensity or the relative intensity given
by the original spectrum do not accurately reflect the
likelihood for a peak being signal. Thus, it is necessary to
develop a better measure to reflect this likelihood. In this
section we focus on this task and develop a measure
called significance level.
According to our experience, four features of a peak may
be associated with the significance of the peak: (1) global
rank, (2) local rank, (3) global intensity ratio, and
(4) local intensity ratio. These four features are explained
in the following, respectively.
The global rank of a peak is the number of peaks (in the
same spectrum) that are higher than or equal to the
current peak. A smaller global rank means a more
significant peak. However, a spectrum of a longer
peptide normally has more signal peaks than a spectrum
of a shorter peptide. With this observation, we further
adjust the global rank by dividing the original ranking
number by the size of the peptide, which is estimated by
dividing the precursor ion mass by the average mass of
an amino acid residue (approximately 112 Da).
The global intensity ratio is the ratio between a global
reference intensity and the intensity of the considered
peak. If this ratio is lower than 1 then it is set to 1. We
consider the following three choices for calculating the
global reference intensity: (a) the intensity of the highest
peak, (b) the intensity of the second highest peak, and
(c) the average intensity of the 3rd to the 10th highest
peaks. The reason we consider choices (b) and (c) is that
some peptides are hard to fragment or can only fragment
on one or two sites, resulting in a spectrum with only a
couple of very high intensity peaks and many very low
signal peaks. The very few extremely high intensity peaks
are really outliers and cannot serve as an accurate
reference. Therefore, it is meaningful to use choices (b)
or (c), which “boost” the low-intensity signal peaks. The
three choices are compared using the training data of
130 spectrum-peptide pairs described in Section Results
as follows: We consider z’-ions, which are z-ions with an
additional hydrogen. There are in total 1206 z’-ions for
the peptides in the training data, of which 1093 match
peaks. These 1093 peaks are regarded as signal peaks.
Then 12060 (10 times of the real z’-ions) random m/z
values are generated to match peaks in the same set of
spectra, giving 3370 randomly matched peaks. These
3370 random peaks are regarded as background noise.
For each of the three choices of the global reference
Table 1: Comparison of the score function in PEAKS and the new score function
Score function Accuracy I Accuracy II Average length Predictions with correct subsequences of length at least x
x = 3 456789 1 0
PEAKS 5.1 0.325 0.342 13.70 0.56 0.46 0.40 0.31 0.24 0.16 0.13 0.12
New score 0.553 0.559 14.26 0.84 0.77 0.64 0.54 0.43 0.37 0.32 0.28
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(ROC) curve for distinguishing the signal peaks from the
background noise. Figure 3 shows the three curves.
Choice (c) has the best ROC curve and is therefore used
in this paper to calculate the global reference intensity
and the global intensity ratio.
The local rank and the local intensity ratio are defined
similarly as their global versions, except that only the
peaks within ±57 Da (the mass of the smallest amino
acid residue) difference to the current peak are exam-
ined. More specifically, the local rank is the number of
peaks which are within ±57 Da difference, and are higher
than or equal to the current peak. Suppose the intensity
of the highest peak within ±57 Da is h1,t h eg l o b a l
reference intensity is h2, the intensity of the current peak
is h, then the local intensity ratio of the current peak is
defined as max (1, min(h1, h2)/h).
All of the above four features contribute some informa-
tion towards the significance of a peak. The significance
level of a peak is calculated as a linear combination of
the natural logarithms of the four features. Let rg, rl, tg
and tl be the global rank, local rank, global intensity ratio
and local intensity ratio of a peak, then its significance
level is
cr cr ct c t rg g rl l tg g tl l log( ) log( ) log( ) log( ), ++ +
where crg, crl, ctg and ctl are the coefficients for the
features. It should be noted that under this definition, a
smaller value for significance level means a stronger
peak. This is somewhat counterintuitive but chosen
deliberately in order to assign the same value 0 to the
strongest peak in every spectrum.
From our experience, the local rank is the most
important feature. An exhaustive search is used to find
the best coefficient combination. We let crl =1 ,a n d
enumerate all possible values of crg, ctg, ctl Œ {0.01,
0.02, ..., 1}. For each combination, the significance level
is evaluated by the area below the ROC curve for
distinguishing the signal peaks and the background
noise in the training data. The search found the best
normalized coefficients to be crg =0 . 2 2 ,crl = 0.40, ctg =
0.05 and ctl = 0.33. The ROC curves with each of the four
features and their best combination for the testing data
are shown in Figure 4. This figure illustrates that the
linear combination of the four features noticeably
improves the ability in distinguishing between real
matched peaks and randomly matched peaks. We point
out that for de novo sequencing, the differences between
the top few sequence candidates are minor, therefore a
small improvement in Figure 4 may cause a large
improvement in the final de novo sequencing results.
Distribution of the peak significance levels for different
ion types
It is well known that different types of mass spectro-
meters (especially if the peptide fragmentation methods
are different) tend to produce different ion types. For
example, CID produces more b and y-ions than other
ion types, while ETD produces more c and z’-ions. Thus,
when using a peptide to explain a spectrum, matching a
high-intensity peak with a z’-ion or a y-ion will have
different contributions towards the likelihood that the
Figure 3
Comparison of the three reference intensities.T h e
ROC curves for the three reference intensities when the
global intensity ratio is used to distinguish z’ signal peaks and
background noise peaks.
Figure 4
The ROC curves for the four features and their best
linear combination.
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z’-ions, the matching with a z’-ion will contribute more
than the matching with a y-ion. Thus it is necessary to
study the distribution of thes i g n i f i c a n c el e v e lf o r
different ion types. In this section we study this with
ETD data. The distribution will help us to develop our
final score function.
By using the same training data of 130 spectrum-peptide
pairs, the distribution of the significance levels for
several common ion types in ETD data are plotted in
Figure 5. Keep in mind that the significance level 0
means the peak is the most significant in a spectrum.
Because the training data is limited in its size (only
approximately 1000 data points for each ion type), the
distributions shown in Figure 5 are not smooth and not
suitable to be used directly in our scoring function. Thus
the following treatment is applied to the data. For each
ion type t, suppose there are n ions of this type from the
given peptides. m of the n ions match peaks in the
spectra. We divide the range of significance level into
four intervals I1, I2, I3, I4,s u c ht h a tIj is left to Ij+1 and
each interval contains m/4 matched peaks. Thus for each
j =1 ,2 ,3 ,4 ,Pr(t ion significance level Œ Ij)= m
n 4 .
Meanwhile we can calculate Pr(random ion significance
level Œ Ij) by simple counting. So, the likelihood ratio of
the two events is calculated as
Pr t I j
Pr
()
(
 ion significance level 
random ion significance
∈
   level ∈I j)
.
Next we define a continuous function f by interpolation
to measure the significance of the event that a type-t peak
has significance level x. Denote the centroid of each
interval Ij by cj.D e f i n e
fc j
Pr t I j
Pr
()l o g
()
(
=
∈  ion significance level 
random ion sign nificance level ∈
⎛
⎝
⎜
⎜
⎞
⎠
⎟
⎟ I j)
.
In addition, let c5 be the centroid of the largest 10%
significance levels in the training data. At significance
level greater than or equal to c5, most peaks are noise.
Therefore, matching one of these peaks with an ion
becomes a very insignificant event, and can be treated as
if the ion does not match any peak. Thus, we define
fc
Pr t
Pr
()l o g
(
( 5 =
 ion does not match peak
random ion does not t match peak)
.
⎛
⎝
⎜
⎞
⎠
⎟
Let f(x)=f(c1)f o rx <c1 and f (x)=f (c5)f o rx >c5.L e tf (x)
for other x be defined by linear interpolation. Thus, f(x)
becomes an approximation to the log likelihood-ratio
between the two hypotheses that the peak is a t-ion
match and a random match. More specifically,
fx
Pr t x
Pr
() l o g
()
(
≈
=  ion significance level
random ion signifi icance level=
⎛
⎝
⎜
⎞
⎠
⎟ x)
.
The curves of f(x) for several different ion types are
shown in Figure 6. This function will be used to develop
our final score function.
The probabilistic model and score function
Almost every score function for measuring the peptide-
spectrum matching relies on the peaks matched by the
theoretical fragment ions of the peptide. In general the
Figure 5
The distributions of the significance levels for
different ion types and random peaks.
Figure 6
The score functions attained from the training data
for different ion types.
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peptide is the correct peptide. However, because there
are different types of ions involved, it is not trivial to
balance the contributions of all ions and combine them
together as a single score value. Here we use the standard
likelihood ratio method to define the score. Consider a
peptide P of length n.S u p p o s et h e r ea r ek ion types t1,. . . ,
tk considered in the score function. Denote all ions of
type ti by ti, j (j =1 ,. . . ,n -1 ) .L e txi, j be the significance
level of the peak that matches ti, j. xi, j = ∞ if the ion
matches no peak. Then the likelihood of observing the
matches xi, j (i =1 ,. . . ,k, j =1 ,. . . ,n -1 )u n d e rt h e
hypothesis that P is the correct peptide is
Pr
tx
ik jn
P
ij ij ,, ,
,, , ,,
 has significance level 
for 
 
== − 11 1 ……
i is correct
⎛
⎝
⎜ ⎜
⎞
⎠
⎟ ⎟.
The likelihood of the matches under the hypothesis that
P is a random peptide is
Pr
tx
ik jn
P
ij ij ,, ,
,, , ,,
 has significance level 
for 
 
== − 11 1 ……
i is random
⎛
⎝
⎜ ⎜
⎞
⎠
⎟ ⎟.
The significance of this match, denoted as l (x1,1, x1,2,. . . ,
xk, n-1), is therefore evaluated by the ratio between these
two likelihoods. In this section we make the assumption
that the events that ti, j has intensity xi, j are independent
to each other. The independence assumption makes our
score function easier to calculate while not sacrificing
much performance on analysis accuracy. A discussion on
the model where the events are dependent can be found
in Section Discussion.
When the events ti, j has intensity xi, j are independent to
each other, the log-likelihood-ratio becomes
log ( , , , )
log
( ,, |
,, , λ xx x
Pr tij xijP
kn 11 12 1 … −
=
 has intensity   is s correct
 has intensity   is random
)
( ,, |) Pr tij xijP
⎛
⎝
⎜
⎜
⎞
⎠
⎟
⎟
i ij
ij ij
ij
fx
,
,,
,
() .
∑
∑ =
(1)
Here fi, j is one of the f functions trained for the j-th ion
of the ion type ti. In practice, for each ion type of interest,
we learn five f functions, for the first and second ions
n e a rt h eN - t e r m i n u s ,t h el a s ta n ds e c o n dl a s ti o n sa tt h e
C-terminus, and the middle of the peptide, respectively.
The log l defined in (1) is our score function.
We still need to decide what types of ions can be
included in the score function for ETD data. Clearly we
want to include the more frequently observed ion types
because they are more distinguishable from noise.
Meanwhile, we do not want to include ion types that
are too dependent to each other because that conflicts
our independence assumption. The frequencies of
observing peaks for a particular ion type in our training
data are listed in Table 2. From the table, we select eight
ions with the highest frequencies for our score function:
z’,c ,y ,b ,a ,y - H 2O, c-H2O, and z’
2+-ion, where z’
2+-ion is
the z’-ion with charge 2. z-ion is not included because it
is highly correlated with z’-ion.
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